Royalty Pharma Reports Q4 and Full Year 2025 Results
Go back to Royalty Pharma Reports Q4 and Full Year 2025 Results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 62.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.32 | 52 Week High | $3.48 | |||
| Open | $62.32 | 52 Week Low | $0.80 | |||
| Day High | $62.32 | P/E | N/A | |||
| Day Low | $62.32 | EPS | $-1.54 | |||
| Volume | 540 | |||||
